https://orcid.org/0000-0003-3631-3941
References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30.
- SEER. Cancer Stat Facts 2020. [December 2, 2020]. Available from: https://seer.cancer.gov/statfacts/
- NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colon Cancer V4.2020 2020. [December 3, 2020]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.
- NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Gastric cancer V3.2020 2020. [December 3, 2020]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.
- McLean J, Rho YS, Kuruba G, et al. Clinical practice patterns in chemotherapeutic treatment regimens for metastatic colorectal cancer. Clin Colorectal Cancer. 2016;15(2):135–140.
- Abrams T, Hess LM, Zhu YE, et al. Predictors of heterogeneity in the first-line treatment of patients with advanced/metastatic gastric cancer in the US. Gastric Cancer. 2018;21(5):738–744.
- Hess LM, Cui ZL, Wu Y, et al. Patient experience after receiving a diagnosis of gastric cancer in the USA. J Gastrointest Cancer. 2018;49(1):25–34.
- Paulson S, Hess LM, Chatterjee A, et al. The impact of a clinical decision support system for advanced gastric or gastroesophageal junction cancer. J Clin Pathways. 2020;6(10):55–64.
- Rhoades SA. The Herfindahl-Hirschman index. Fed Res Bull. 1993;79:188.
- HHS. Human Subject Regulations Decision Charts: 2018 Requirements 2020. [March 10, 2021]. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/decision-charts-2018/index.html#c1.
- Hess LM, Li X, Wu Y, et al. Defining treatment regimens and lines of therapy using real-world data in oncology. Future Oncol. 2021;17(15):1865–1877.
- Cutler DM, Morton FS. Hospitals, market share, and consolidation. JAMA. 2013;310(18):1964–1970.
- Wright JD, Chen L, Accordino M, et al. Regional market competition and the use of immediate breast reconstruction after mastectomy. Ann Surg Oncol. 2019;26(1):62–70.
- Whyte JL, Engel-Nitz NM, Teitelbaum A, et al. An evaluation of algorithms for identifying metastatic breast, lung, or colorectal cancer in administrative claims data. Med Care. 2015;53(7):e49–e57.